NASDAQ : ACON
Aclarion, Inc. — Financial statements
Healthcare · Health Information Services · United States
Last price 1.95 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Aclarion, Inc. (ACON) reported revenue of 83.77K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 83.77K | 75.73K | 45.72K | 75.40K | 60.44K | 60.29K |
| Cost of Revenue | 65.55K | 68.90K | 84.66K | 75.73K | 65.30K | 69.17K |
| Gross Profit | 18.22K | 6.83K | -38.93K | -324.00 | -4.85K | -8.88K |
| Selling, General & Admin | 8.55M | 6.03M | 4.59M | 4.00M | 4.49M | 2.16M |
| Research & Development | 1.18M | 1.03M | 888.77K | 873.34K | 1.07M | 787.85K |
| Operating Expenses | 9.73M | 7.06M | 5.47M | 4.88M | 5.56M | 2.94M |
| Operating Income | -9.71M | -7.05M | -5.51M | -4.88M | -5.56M | -2.95M |
| Interest Expense | -535.47K | -608.29K | -1.51M | -474.91K | ||
| Interest & Investment Income | 523.41K | 411.06K | 318.00 | 172.00 | 2.51K | |
| Currency Exchange Gain (Loss) | 145.00 | -1.19K | -1.31K | |||
| Other Non Operating Income (Expenses) | -9.23K | 7.05K | 334.98K | 572.58K | -800.00 | -1.90M |
| EBT Excluding Unusual Items | -9.20M | -6.63M | -5.71M | -4.91M | -7.07M | -5.33M |
| Other Unusual Items | -125.00 | -599.35K | -1.28M | 378.51K | ||
| Pretax Income | -9.20M | -7.23M | -6.99M | -4.91M | -7.07M | -4.95M |
| Net Income | -9.20M | -7.23M | -6.99M | -4.91M | -7.07M | -4.95M |
| Preferred Dividends & Other Adjustments | 6.68K | 59.67K | 415.52K | 1.01M | ||
| Net Income to Common | -9.20M | -7.24M | -7.05M | -4.91M | -7.48M | -5.96M |
| Shares Outstanding (Basic) | 1.48M | 532.04K | ||||
| Shares Outstanding (Diluted) | 1.48M | 532.04K | ||||
| EPS (Basic) | -6.22 | -13.61 | ||||
| EPS (Diluted) | -6.22 | -13.61 | ||||
| Free Cash Flow | -8.11M | -7.19M | -5.28M | -3.65M | -4.95M | -2.40M |
| Free Cash Flow Per Share | -5.48 | -13.51 | ||||
| Gross Margin | 21.75% | 9.02% | -85.15% | -0.43% | -8.03% | -14.73% |
| Operating Margin | -11,592.14% | -9,312.55% | -12,057.23% | -6,466.47% | -9,201.19% | -4,897.89% |
| Profit Margin | -10,978.48% | -9,560.69% | -15,424.29% | -6,513.41% | -12,381.90% | -9,878.40% |
| Free Cash Flow Margin | -9,680.86% | -9,488.62% | -11,540.38% | -4,836.54% | -8,187.93% | -3,980.54% |
| EBITDA | -9.47M | -6.82M | -5.32M | -4.71M | -5.42M | -2.77M |
| D&A For EBITDA | 242.46K | 227.41K | 193.14K | 162.67K | 143.62K | 186.39K |
| EBIT | -9.71M | -7.05M | -5.51M | -4.88M | -5.56M | -2.95M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 16.29M | 12.02M | 453.66K | 1.02M | 1.47M | 432.53K |
| Short-Term Investments | 10.00K | 10.00K | 39.00K | 50.00K | ||
| Cash & Short-Term Investments | 16.30M | 12.03M | 492.66K | 1.07M | 1.47M | 432.53K |
| Accounts Receivable | 28.17K | 29.68K | 18.33K | 13.27K | 18.57K | 6.28K |
| Other Receivables | 154.00 | |||||
| Receivables | 28.17K | 29.68K | 18.33K | 13.42K | 18.57K | 6.28K |
| Prepaid Expenses | 445.57K | 316.24K | 183.56K | 94.29K | 199.70K | 273.39K |
| Restricted Cash | 25.00K | 25.00K | 10.00K | 10.00K | 10.00K | 20.00K |
| Other Current Assets | 119.73K | 100.59K | ||||
| Total Current Assets | 16.79M | 12.40M | 824.28K | 1.29M | 1.70M | 732.20K |
| Property, Plant & Equipment | 23.23K | 24.17K | 5.50K | 1.78K | 3.35K | 12.64K |
| Other Intangible Assets | 1.22M | 1.25M | 1.29M | 1.17M | 1.21M | 1.14M |
| Total Assets | 18.04M | 13.67M | 2.12M | 2.46M | 2.91M | 1.89M |
| Accounts Payable | 704.98K | 332.96K | 531.60K | 760.53K | 462.20K | 1.07M |
| Accrued Expenses | 331.91K | 504.26K | 529.18K | 857.72K | 226.47K | 696.58K |
| Short-Term Debt | 1.13M | 2.00M | ||||
| Other Current Liabilities | 45.00 | 63.00 | 92.64K | 443.79K | 3.86M | |
| Total Current Liabilities | 1.04M | 837.29K | 1.15M | 3.19M | 688.67K | 7.62M |
| Total Liabilities | 1.04M | 837.29K | 1.15M | 3.19M | 688.67K | 7.62M |
| Common Stock | 25.00 | 9.00 | 5.00 | 9.00 | ||
| Additional Paid-In Capital | 81.10M | 71.33M | 52.23M | 43.55M | 41.60M | 19.05M |
| Retained Earnings | -64.10M | -58.50M | -51.26M | -44.28M | -39.37M | -31.89M |
| Total Common Equity | 17.00M | 12.84M | 970.06K | -728.00K | 2.23M | -12.83M |
| Shareholders' Equity | 17.00M | 12.84M | 970.06K | -728.00K | 2.23M | -5.73M |
| Total Liabilities & Equity | 18.04M | 13.67M | 2.12M | 2.46M | 2.91M | 1.89M |
| Total Debt | 1.13M | 2.00M | ||||
| Net Cash (Debt) | 16.30M | 12.03M | 492.66K | -54.66K | 1.47M | -1.57M |
| Net Cash Per Share | 11.01 | 22.60 | ||||
| Filing Date Shares Outstanding | 2.88M | 2.28M | 582.37K | |||
| Total Common Shares Outstanding | 2.46M | 854.37K | ||||
| Working Capital | 15.76M | 11.56M | -329.15K | -1.90M | 1.01M | -6.89M |
| Book Value Per Share | 6.91 | 15.02 | ||||
| Tangible Book Value | 15.78M | 11.58M | -323.65K | -1.90M | 1.02M | -13.98M |
| Tangible Book Value Per Share | 6.41 | 13.56 | ||||
| Machinery | 27.74K | 25.93K | 18.15K | 13.03K | 31.22K | 71.08K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -9.20M | -7.23M | -6.99M | -4.91M | -7.07M | -4.95M |
| Depreciation & Amortization | 242.46K | 227.41K | 193.14K | 162.67K | 143.62K | 186.39K |
| Other Amortization | 471.39K | 497.66K | ||||
| Loss (Gain) From Sale of Assets | 3.79K | |||||
| Stock-Based Compensation | 127.92K | 105.37K | 287.45K | 456.00K | 1.29M | 177.49K |
| Other Operating Activities | -58.00 | 94.55K | 1.33M | -474.77K | 1.30M | 1.56M |
| Change in Accounts Receivable | -7.25K | -11.35K | 7.27K | -1.49K | -12.29K | 16.22K |
| Change in Accounts Payable | 442.44K | -198.64K | -156.40K | 220.63K | -603.10K | 199.60K |
| Change in Other Net Operating Assets | 304.35K | -147.91K | -415.11K | 403.73K | -703.00 | 413.45K |
| Operating Cash Flow | -8.09M | -7.16M | -5.27M | -3.65M | -4.95M | -2.40M |
| Capital Expenditures | -22.86K | -21.53K | -5.12K | |||
| Sale of Property, Plant & Equipment | 1.00K | |||||
| Sale (Purchase) of Intangibles | -151.28K | -182.37K | -316.82K | -119.52K | -208.87K | -102.00K |
| Investing Cash Flow | -174.14K | -203.90K | -321.94K | -119.52K | -207.87K | -102.00K |
| Short-Term Debt Issued | 2.25M | 2.94M | ||||
| Total Debt Issued | 2.25M | 2.94M | ||||
| Short-Term Debt Repaid | -300.97K | -2.00M | ||||
| Total Debt Repaid | -300.97K | -2.00M | ||||
| Net Debt Issued (Repaid) | -300.97K | 2.25M | -2.00M | 2.94M | ||
| Issuance of Common Stock | 1.57M | 20.59M | 5.57M | 1.46M | 8.55M | |
| Other Financing Activities | 10.15M | -435.13K | -1.25M | -398.22K | -365.06K | |
| Financing Cash Flow | 11.72M | 18.95M | 5.03M | 3.31M | 6.19M | 2.94M |
| Net Cash Flow | 3.46M | 11.58M | -567.41K | -451.74K | 1.03M | 437.55K |
| Free Cash Flow | -8.11M | -7.19M | -5.28M | -3.65M | -4.95M | -2.40M |
| Free Cash Flow Margin | -9,680.86% | -9,488.62% | -11,540.38% | -4,836.54% | -8,187.93% | -3,980.54% |
| Free Cash Flow Per Share | -5.48 | -13.51 | ||||
| Levered Free Cash Flow | -5.32M | -4.63M | -4.17M | -1.05M | -8.05M | -2.48M |
| Unlevered Free Cash Flow | -5.32M | -4.63M | -3.84M | -667.34K | -7.11M | -2.18M |
| Cash Interest Paid | 13.07K | |||||
| Cash Income Tax Paid | 2.49K | 1.69K | ||||
| Change in Working Capital | 739.54K | -357.90K | -564.24K | 622.87K | -616.10K | 629.27K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.62M | 3.09M | 1.50M | 1.74M | 4.53M | |
| Enterprise Value | -10.67M | -8.29M | 140.95K | 2.30M | 1.88M | |
| Last Close Price | 1.95 | 4.60 | 1,302.47 | 28,943.98 | 83,937.54 | |
| PS Ratio | 67.10 | 40.78 | 32.87 | 23.03 | 74.99 | |
| PB Ratio | 0.28 | 0.24 | 1.55 | -2.39 | 2.04 | |
| P/TBV Ratio | 0.36 | 0.27 | 4.46 | |||
| EV/Sales Ratio | 3.08 | 30.54 | 31.05 | |||
| Debt / Equity Ratio | -1.55 | -0.35 | ||||
| Net Debt / Equity Ratio | -0.96 | -0.94 | -0.51 | -0.07 | -0.66 | -0.27 |
| Net Debt / EBITDA Ratio | 1.72 | 1.76 | 0.09 | -0.01 | 0.27 | -0.57 |
| Net Debt / FCF Ratio | 2.01 | 1.67 | 0.09 | -0.01 | 0.30 | -0.65 |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 |
| Quick Ratio | 15.74 | 14.40 | 0.44 | 0.34 | 2.17 | 0.06 |
| Current Ratio | 16.20 | 14.81 | 0.71 | 0.40 | 2.47 | 0.10 |
| Return on Equity (ROE) | -58.97% | -104.80% | -5,777.80% | -655.74% | ||
| Return on Assets (ROA) | -37.01% | -55.81% | -150.36% | -113.41% | -144.71% | -116.03% |
| Return on Capital Employed (ROCE) | -57.10% | -54.90% | -568.30% | 669.80% | -249.90% | 51.50% |
| Earnings Yield | -318.74% | -234.23% | -465.25% | -282.81% | -155.95% | |
| FCF Yield | -144.28% | -232.68% | -351.07% | -210.00% | -109.19% |